The earnings call presented a strong quarter for IDEXX with significant revenue and EPS growth, driven by robust international performance and record instrument placements. However, challenges such as a decline in U.S. clinical visits and a dip in Rapid assay revenues were noted. Despite these lowlights, the overall sentiment of the call leans positive due to the outweighing highlights and an optimistic outlook for the remainder of 2025.

Company Guidance -

Q3 2025

In the second quarter of 2025, IDEXX Laboratories reported robust financial results, driven by strong global execution in the companion animal business and increasing adoption of IDEXX innovations. The company achieved a reported revenue growth of 11%, with organic growth at 9%, highlighted by a 7.5% increase in CAG Diagnostic Recurring Revenues. Internationally, organic revenue growth reached double digits at 11%, contrasting a 2.5% decline in U.S. same-store clinical visit growth. Operating profit grew by 14% on a comparable basis, supported by a 27% benefit from lapping a discrete litigation expense in Q2 2024. This performance resulted in an earnings per share of $3.63, marking a 17% EPS growth. IDEXX increased its full-year revenue outlook by $90 million, with expectations for overall organic revenue growth between 7% to 9%. The company also raised its EPS outlook to $12.40 to $12.76, reflecting projected full-year EPS growth of 9% to 13%.

Strong Revenue Growth

IDEXX reported an 11% increase in revenue, with organic growth at 9%. This was supported by a 7.5% organic growth in CAG Diagnostic Recurring Revenues and a 62% increase in CAG Diagnostic instrument revenues.

Record Instrument Placements

The company reported a record quarter for premium instrument placements, including nearly 2,400 IDEXX inVue DX instruments, and a total of 6,070 units, marking a 23% year-over-year increase.

EPS Growth

Earnings per share grew by 17% on a comparable basis, reaching $3.63 per share, aided by share-based compensation and a tax reserve release.

Increased 2025 Revenue and EPS Outlook

IDEXX increased its full-year revenue outlook by $90 million at midpoint and EPS outlook by $0.40 at midpoint, reflecting strong operational performance and favorable foreign exchange impacts.

Strong International Performance

International regions saw 11% organic CAG Diagnostic recurring revenue growth, marking the tenth consecutive quarter of double-digit installed base growth.

Idexx Laboratories (IDXX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IDXX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	3.13 / -	2.8	―	―	―
Aug 04, 2025	2025 (Q2)	3.30 / 3.63	2.44	48.77% (+1.19)
May 01, 2025	2025 (Q1)	2.85 / 2.96	2.81	5.34% (+0.15)
Feb 03, 2025	2024 (Q4)	2.40 / 2.62	2.32	12.93% (+0.30)
Oct 31, 2024	2024 (Q3)	2.68 / 2.80	2.53	10.67% (+0.27)
Aug 06, 2024	2024 (Q2)	2.88 / 2.44	2.67	-8.61% (-0.23)
May 01, 2024	2024 (Q1)	2.71 / 2.81	2.55	10.20% (+0.26)
Feb 05, 2024	2023 (Q4)	2.12 / 2.32	2.05	13.17% (+0.27)
Nov 01, 2023	2023 (Q3)	2.37 / 2.53	2.15	17.67% (+0.38)
Aug 01, 2023	2023 (Q2)	2.47 / 2.67	1.56	71.15% (+1.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IDXX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 04, 2025	$535.54	$682.78	+27.49%
May 01, 2025	$432.65	$471.38	+8.95%
Feb 03, 2025	$422.05	$469.04	+11.13%
Oct 31, 2024	$451.08	$406.92	-9.79%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Idexx Laboratories (IDXX) report earnings?

Idexx Laboratories (IDXX) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).

What is Idexx Laboratories (IDXX) earnings time?

Idexx Laboratories (IDXX) earnings time is at Nov 04, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is IDXX EPS forecast?

IDXX EPS forecast for the fiscal quarter 2025 (Q3) is 3.14.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing